Share on Pinterest Weight loss drugs could help improve health outcomes in people with heart failure. The Good Brigade/Getty Images Researchers report that the weight loss drugs semaglutide and ...
High-risk patients with heart failure had an over 40 percent lower risk of hospitalization or death after initiating weight loss drugs semaglutide or tirzepatide compared to placebo by proxy, ...
A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results